Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadavist in CNS MRI
NCT00623467Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of gadobutrol in Central nervous system diseases, sponsored by Bayer. Started Dec 2007; status: completed.
02
Drugs
gadobutrol
03
Conditions
Central nervous system diseases
Beyond the preview
Go deeper on NCT00623467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623467.